After adjusting for traditional vascular risk factors, radiologists encourage aggressive monitoring of COVID-19 patients for blood flow changes to the brain.
There is a significant link between the virus that causes COVID-19 and strokes, newly published research reveals, indicating providers should adjust their treatment of these patients accordingly.
In the American Journal of Neuroradiology, investigators from Ichan School of Medicine at Mount Sinai published the results of an evaluation of more than 120 patients admitted for possible stroke during the pandemic to six New York City hospitals. Their findings indicate that clinicians should more actively monitor these patients to identify any problems as soon as possible.
“This is the first major peer-reviewed study to show that COVID-19 infection is a risk factor for acute strokes,” said lead study author Puneet Belani, M.D., assistant professor of radiology and neurosurgery. “Patients with COVID-19 should be evaluated early for acute neurological changes and timely workup should be performed in patients suspected to have stroke to reduce morbidity and mortality.”
Belani’s team conducted a retrospective, case-control study with 41 patients. Each patient had a stroke confirmed with non-contrast head CT followed by vascular imaging, and the researchers compared that analysis to 82 control participants who, with the same image confirmation, had no evidence of stroke.
Based on their evaluation, they determined that more than 46 percent of patients with acute ischemic stroke also had COVID-19 infection. The same was true for only 18 percent of the control group. After they adjusted for sex, age, and other risk factors, the association between the virus and stroke was clear.
“We found that COVID-19 is an independent risk factor for imaging-confirmed acute ischemic stroke during stroke alert evaluation, after controlling for traditional vascular risk factors,” the team said. “This finding suggests that COVID-19 infection is associated with increased morbidity and mortality that transcends the primary cardiopulmonary sequelae from the infection.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.